A5002204668- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Advanced Radiotherapy Techniques
- Breast Cancer Treatment Studies
- Cancer Diagnosis and Treatment
- Effects of Radiation Exposure
- Breast Implant and Reconstruction
- Animal Behavior and Reproduction
- Bladder and Urothelial Cancer Treatments
- Urinary Bladder and Prostate Research
- Hypothalamic control of reproductive hormones
- Global Cancer Incidence and Screening
- Clinical practice guidelines implementation
- Urologic and reproductive health conditions
- Avian ecology and behavior
- Economic and Financial Impacts of Cancer
- Thyroid Cancer Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Colorectal Cancer Surgical Treatments
- Advances in Oncology and Radiotherapy
- Radiomics and Machine Learning in Medical Imaging
- Radiation Effects and Dosimetry
- Testicular diseases and treatments
- Medical Imaging Techniques and Applications
- Radiology practices and education
University of Calgary
2010-2023
Roslin Institute
2021
University of Edinburgh
2021
Alberta Health Services
2021
BC Cancer Agency
2016-2018
University of British Columbia
2017-2018
University of Toronto
2008-2013
University Health Network
2011
Wake Forest University
2010
Princess Margaret Cancer Centre
2008
A study was performed to identify variables that affected cause-specific survival (CSS) and local relapse-free rate (LRFR) in patients with differentiated thyroid cancer (DTC) extrathyroid extension (ETE) examine the role of external beam radiotherapy (XRT). Prognostic factors were similar those found studies all DTC. In postoperative gross residual disease treated radiotherapy, 10-year CSS LRFR 48% 90%. For no or microscopic disease, 92% 93%. older than 60 years T3 ETE but postoperatively...
ment that facilitated the sharing of knowledge to aid in consensus development.This paper highlights treatment issues related use salvage radiotherapy following radical prostatectomy and summarizes recommendations put forth by group.The document on role adjuvant was reported a separate article. 2 BackgroundRadical is well-established modality provides excellent control localized prostate cancer.4][5] Although possibility benign cause persistent elevation serum prostate-specific antigen (PSA)...
Patients have reported late effects and symptom-related bother following postoperative radiotherapy for prostate cancer.Patients treated with were surveyed at a median 56 months after using the Prostate Cancer Radiation Therapy instrument. A retrospective review was undertaken to obtain Oncology Group-Late Effects Normal Tissue (RTOG-LENT) toxicity scores baseline during follow-up.Survey response 64.5%. Median bed radiation dose 66 Gy given 14 surgery. Adjuvant hormone therapy 2 3 years 40...
Abstract Across taxa, the seasonal transition between non‐breeding and breeding states is controlled by localised thyroid hormone signalling in deep brain via reciprocal switching of deiodinase enzyme expression from type 3 (DIO3) to 2 (DIO2). This switch considered be mediated increasing thyroid‐stimulating β (TSHβ) release pars tuberalis, which occurs response a change photoperiod. Although well characterised handful model organisms laboratory settings, this pathway remains largely...
Adjuvant radiotherapy (aRT) can improve biochemical progression-free survival in patients with high-risk features (HRF) after radical prostatectomy (RP). Guidelines from Alberta and the Genitourinary Radiation Oncologists of Canada (GUROC) recommend that HRF be referred to radiation oncologists (RO) based on findings three randomized, controlled trials (RCT). Our study examines impact these recommendations both pre- (2005) post- (2012) publication RCT GUROC guideline establishment.Patients...
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Martell K, Meyer T, Sia M, Angyalfi S, Husain S. Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative brachytherapy. Journal of Contemporary Brachytherapy. 2017;9(2):99-105. doi:10.5114/jcb.2017.67198. APA Martell, K., Meyer, T., Sia, M., Angyalfi, S., & Husain, (2017). Brachytherapy, 9(2), 99-105. https://doi.org/10.5114/jcb.2017.67198 Chicago Kevin,...
Residency experiences and teaching in oncology among urology residents are variable across Canada. We sought to identify how radiation medical concepts, as they pertain genitourinary malignancies, taught residents.A total of 190 trainees enrolled Canadian residency training programs were invited participate the study from January 2016 June 2016. Participants completed an online questionnaire addressing received.The overall response rate was 32%. Twenty-three percent respondents their...
In Canada, as of July 25, 2020, over 115,000 cases COVID-19 have been diagnosed. That number is anticipated to grow until between 30% and 70% the population infected (11–26 million people) [[1]Statistics Canada. Coronavirus Summ 2020. https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19.html (accessed March 31, 2020).Google Scholar]. This despite advantages disease control having a small (37 million) spread large geographic area (10 square km with varying...
We aimed to determine the impact of clinical practice guidelines (CPG) on rates radiation oncologist (RO) referral, androgen-deprivation therapy (ADT), (RT), and radical prostatectomy (RP) in patients with high-risk prostate cancer (HR-PCa).All men >18 years, diagnosed PCa 2005 2012 were identified from Alberta Cancer Registry. Patient age, aggregated risk group (ACRG) score, Gleason score (GS), pre-treatment prostate-specific antigen (PSA), RO treatment received extracted electronic medical...
Radical treatment of localized prostate cancer in elderly patients may lead to unacceptable treatment-associated toxicities that adversely impact quality life without improving survival outcomes. This study reports on a cohort 54 (>70 years) received 4000-5000 cGy palliative external beam radiotherapy (EBRT) as an alternative androgen deprivation therapy (ADT). The primary outcome interest was the period ADT-free survival, and secondary outcomes included overall (OS) metastases-free (MFS)....